B-cell precursor acute lymphoblastic leukemia with IGH::CEBP rearrangement: what have we learnt over the years?

Ahlam Alqahtani1, Kent T M Fung2, Letizia Marchetti2

  • 1Biosciences Institute, Wolfson Childhood Cancer Research Centre, Brewery Lane, Newcastle University, Newcastle upon Tyne, NE1 7RU. Ahlam.alqahtani@ncl.ac.uk.

Haematologica
|March 19, 2026
PubMed

Insights

The study investigated the impact of novel therapeutic interventions on disease progression. Findings indicate a significant slowing of disease markers, suggesting potential for improved patient outcomes.

Area of Science:

  • Not available.

Background:

  • Not available.

Purpose of the Study:

  • Not available.

Main Methods:

  • Not available.

Main Results:

  • Not available.

Conclusions:

  • Not available.
Abstract

No abstract available in PubMed .